The phosphorylation characteristics of insulin receptor from control and insulin-treated rat H-35 hepatoma cells 32P-labeled to equilibrium have been documented. The 32P-labeled insulin receptor is isolated by immunoprecipitation with patient-derived insulin receptor antibodies in the presence of phosphatase and protease inhibitors to preserve the native phosphorylation and structural characteristics of the receptor. The unstimulated insulin receptor contains predominantly [32P] phosphoserine and trace amounts of [32P]phosphothreonine in its beta subunit. In response to insulin, the insulin receptor beta subunit exhibits marked tyrosine phosphorylation and a 2-fold increase in total [32P]phosphoserine contents. High pressure liquid chromatography of the tryptic hydrolysates of the 32P-labeled receptor beta subunit from quiescent cells results in the resolution of up to 9 fractions containing [32P]phosphoserine. The insulin-stimulated tyrosine phosphorylation is concentrated in two of these receptor phosphopeptide fractions, whereas the increase in [32P]phosphoserine content is scattered in low abundance over all receptor tryptic fractions. Insulin receptors affinity-purified by lectin- and insulin-agarose chromatographies from insulin-treated, 32P-labeled cells exhibit a 22-fold increase in the Vmax of receptor tyrosine kinase activity toward histone when compared to controls. The elevated kinase activity of the insulin receptor derived from insulin-treated cells is not due to the presence of hormone bound to the receptor because the receptor kinase activity is assayed while immobilized on insulin-agarose. Furthermore, the insulin-activated receptor kinase activity is reversed following dephosphorylation of the receptor beta subunit with alkaline phosphatase in vitro. The correlation between the insulin-stimulated site specific tyrosine phosphorylation on receptor beta subunit and the elevation of receptor tyrosine kinase activity strongly suggests that the insulin receptor kinase is activated by hormone-stimulated autophosphorylation on tyrosine residues in intact cells, as previously demonstrated for the purified receptor.
Multiplication-stimulating activity (MSA) stimulates the uptake of xylose and alpha-aminoisobutyric acid (AIB) by intact rat soleus muscle. It is approximately 50 times less potent than insulin. A native insulin receptor species with apparent Mr = 350,000 in soleus muscle is revealed by affinity cross-linking to 125I-insulin with disuccinimidyl suberate. 125I-labeled insulin-like growth factor (IGF) I with the cross-linker affinity labels two native receptor types with Mr = 360,000 (type I) and Mr = 220,000 (type II). In order to distinguish which of the three insulin and IGF receptor systems identified mediate the rapid insulin-like effects of MSA, the biological actions of the unlabeled ligands at various concentrations were correlated with their ability to inhibit the affinity labeling of these receptor species. The stimulatory action of native insulin is closely related to its ability to inhibit the labeling of the insulin receptor by 125I-insulin such that the uptake of xylose and AIB is maximally stimulated when 80% of insulin receptor 125I-affinity labeling is inhibited. In contrast, MSA only displaced 16% of the 125I-labeling of the insulin receptor when it maximally stimulates the uptake of xylose and AIB, indicating that the insulin receptor is not primarily involved in mediating these effects. The affinity of MSA to the type II IGF receptor is 10 times higher than that to the type I IGF receptor. There is close to a 1:1 relationship between the stimulatory effects of MSA on xylose and AIB uptake and its inhibitory action on the affinity labeling of the type I receptor by 125I-IGF I. In contrast, MSA almost abolishes the labeling of the type II IGF receptor at concentrations which have no detectable effects on the uptake of xylose and AIB by soleus muscle. Thus, a marked dissociation can be observed between the rapid insulin-like action of MSA and its inhibitory effects on the affinity labeling of the type II receptor by 125I-IGF I. We conclude that MSA acts through the type I IGF receptor in soleus muscle to stimulate hexose and amino acid transport. The type II IGF receptor appears to be incapable of modulating these effects in this tissue.
The action of insulin on tyrosine phosphorylation of plasma membrane-associated proteins in rat adipocytes was investigated. Incubation of plasma membranes from insulin-treated adipocytes with [gamma-32P] ATP results in a marked increase in tyrosine phosphorylation of Mr = 160,000 (P160) and Mr = 92,000 proteins when compared to controls. Based on the immunoreactivities of these two proteins with anti-insulin receptor antibodies, the Mr = 92,000 species is identified as the insulin receptor beta subunit while P160 is unrelated to the receptor structure. P160 appears to be a glycoprotein as evidenced by its adsorption to wheat germ agglutinin-agarose. The tyrosine phosphorylation of P160 exhibits a rapid response to insulin (maximal within 2 min at 37 degrees C) and is readily reversed following removal of the free hormone by anti-insulin serum. The time courses of insulin-stimulated phosphorylation as well as the dephosphorylation of P160 coincide with those of the activation and deactivation of the insulin receptor kinase in the same plasma membrane preparation. Concanavalin A and hydrogen peroxide mimic insulin stimulation of the insulin receptor kinase and enhance the tyrosine phosphorylation of P160. Isoproterenol, epidermal growth factor, and phorbol diester are without effects. Analysis of the insulin dose-response relationship between P160 tyrosine phosphorylation and insulin receptor kinase activity reveals that maximal phosphorylation of P160 occurs when only a fraction (25%) of the receptor kinase is activated by the hormone. A similar relationship between these two parameters is observed for the insulinomimetic agent hydrogen peroxide. The close correlation between the level of P160 phosphorylation and insulin receptor kinase activity suggests that P160 may be tyrosine phosphorylated by the receptor kinase following receptor kinase activation by the hormone or insulin-like agents. This hypothesis is further supported by the finding that the insulin receptor kinase is the only insulin-sensitive tyrosine kinase detectable in adipocyte plasma membranes under the conditions of our experiments.
Triton X-100-solubilized high-density microsomes from insulin-treated rat adipocytes exhibit a marked increase in serine/threonine and tyrosine kinase activities toward exogenous histone when compared to controls. The insulin-dependent activation of microsomal histone kinase activities occurs within the physiological range of hormone concentrations (ED50 = 0.6 nM). The hormone-enhanced histone phosphorylation by the high-density microsomes appears to be catalyzed by two distinct kinases, based on their differential interaction with wheat germ agglutinin-agarose. The insulin-sensitive serine/threonine kinase is not retained by The insulin-sensitive serine/threonine kinase is not retained by the lectin column, whereas the tyrosine kinase appears to be a glycoprotein as evidenced by its adsorption to the immobilized lectin. The insulin-stimulated serine/threonine kinase exhibits preferential phosphorylation of histone and Kemptide (synthetic Leu-Arg-Arg-Ala-Ser-Leu-Gly) compared to a number of other peptide substrates. The substrate specificity of this serine/threonine kinase shows that it is distinct from the kinases that phosphorylate ribosomal protein S6, casein, phosvitin, ATP citrate lyase, and glycogen synthase and from multifunctional calmodulin-dependent, cAMP- and cGMP-dependent, and Ca2+/phospholipid-dependent protein kinases. Furthermore, 22% of the insulin-sensitive serine/threonine kinase activity can be adsorbed by monoclonal anti-phosphotyrosine antibodies immobilized on agarose. Its adsorption is specifically inhibited by excess free phosphotyrosine but not phosphoserine or phosphothreonine. The data suggest that this insulin-stimulated serine/threonine kinase in adipocyte high-density microsomes is tyrosine-phosphorylated, consistent with the hypothesis that the stimulatory action of insulin on this kinase may be mediated by tyrosine phosphorylation.
The specific binding of 125I-insulin by rat soleus muscle was depressed when muscle ATP was depleted, either by prolonged anoxia or more rapidly with 2,4-dinitrophenol. Insulin binding was not eliminated in ATP-depleted muscle, but was reduced by 70--80%. Insulin binding by aerobic muscle could be resolved into two components; a high-affinity, low-capacity site (KD = 7.8 nM) and a low-affinity, high-capacity site (KD = 390 nM). The stimulatory effect of insulin on xylose uptake could be correlated with binding to the high-affinity site. These results indicate that there is some ATP-dependent process involved in the regulation of insulin binding by soleus muscle. It is suggested that this could be a phosphorylation-dephosphorylation system, acting either on the receptor itself or on some closely related membrane protein.
Materiak-Anti-2,4-dinitrophenyl (DNP) monoclonal mouse IgE and Staphylococcus aureus strain V8 protease were from Sigma.DNPbovine serum albumin (DNP-BSA) was from Behring Diagnostics.['HISerotonin was from Amersham Corp. Cell culture media were from Gibco.Electrophoresis and immunoblotting media and reagents 22564
